nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

04.04.2021 | COVID-19 | Letter to the Editor Zur Zeit gratis

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

verfasst von: Chia Siang Kow, Syed Shahzad Hasan

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID-19, several drugs have been repurposed for its treatment. However, a drug with widespread availability around the globe is particularly desirable to be repurposed for the treatment of COVID-19, since it could be immediately trialed in large-scale studies, and immediate access could be guaranteed shall the drug is proven effective to reduce the risk of COVID-19 associated deaths. One of the first drugs to be introduced for routine usage in the medical field - aspirin (also known as acetylsalicylic acid), is still one of the most widely used medications, with an estimated 50–120 billion pills consumed each year [2]. In addition, it is one of the most researched drugs in the world, with an estimated 700–1000 clinical trials conducted annually [3]. …

Nur mit Berechtigung zugänglich

Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. https://coronavirus.jhu.edu/map.html. Accessed 26 Dec, 2020

Signorelli SS, Platania I, Tomasello SD et al (2020) Insights from experiences on antiplatelet drugs in stroke prevention: a review. Int J Environ Res Public Health 17(16):5840CrossRefPubMedCentral

Connelly (2014) A history of aspirin. Pharm J 6(7):20066661

Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M (2020) Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19 ? Drugs 80(14):1383–1396CrossRefPubMedPubMedCentral

Gu SX, Tyagi T, Jain K et al (2020) Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 18(3):194–209CrossRefPubMedPubMedCentral

Boyle AJ, Di Gangi S, Hamid UI et al (2015) Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care 19(1):109CrossRefPubMedPubMedCentral

Chen W, Janz DR, Bastarache JA et al (2015) Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med 43(4):801–807CrossRefPubMedPubMedCentral

Hasan SS, Capstick T, Ahmed R et al (2020) Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med 14(11):1149–1163CrossRefPubMed

Ho G, Dusendang JR, Schmittdiel J, Kavecansky J, Tavakoli J, Pai A (2021) Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-021-02383-wCrossRefPubMedCentralPubMed

10.

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 26 Dec, 2020

11.

Yuan S, Chen P, Li H, Chen C, Wang F, Wang DW (2020) Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease. J Cell Mol Med. https://doi.org/10.1111/jcmm.16198CrossRefPubMedCentralPubMed

12.

Sahai A, Bhandari R, Koupenova M et al (2020) SARS-CoV-2 receptors are expressed on human platelets and the effect of aspirin on clinical outcomes in COVID-19 patients. Preprint. Res Square. rs.3.rs-119031/v1

13.

Osborne TF, Veigulis ZP, Arreola DM, Mahajan SM, Röösli E, Curtin CM (2021) Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration. PLoS ONE 16(2):e0246825CrossRefPubMedPubMedCentral

14.

Meizlish ML, Goshua G, Liu Y et al (2021) Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. Am J Hematol 20:21. https://doi.org/10.1002/ajh.26102CrossRef

15.

Chow JH, Khanna AK, Kethireddy S et al (2020) Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized patients with COVID-19. Anesth Analg. https://doi.org/10.1213/ANE.0000000000005292CrossRefPubMedCentralPubMed

16.

Liu Q, Huang N, Li A et al (2021) Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19. Medicine 100(6):e24544CrossRefPubMedPubMedCentral

17.

Abu-Jamous B, Anisimovich A, Baxter J et al. Associations of comorbidities and medications with COVID-19 outcome: A retrospective analysis of real-world evidence data. Preprint. medRxiv. 2020;2020.08.20.20174169

18.

Yong X, Wong KCY, So H. Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categories. Preprint. medRxiv. 2020;2020.12.05.20244426

19.

Russo V, Di Maio M, Attena E et al (2020) Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study. Pharmacol Res 159:104965CrossRefPubMedPubMedCentral

20.

Fröhlich GM, Jeschke E, Eichler U et al (2021) Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01783-xCrossRefPubMedCentralPubMed

21.

Tremblay D, van Gerwen M, Alsen M et al (2020) Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Blood 136(1):144–147CrossRefPubMed

Titel: Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
verfasst von: Chia Siang Kow
Syed Shahzad Hasan
Publikationsdatum: 04.04.2021
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 1/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-021-02436-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Massive intraperitoneal hemorrhage in patients with COVID-19: a case series

Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus

Major bleeding complications in critically ill patients with COVID-19 pneumonia

Small lipid core burden index in patients with stable angina pectoris is also associated with microvascular dysfunction: Insights from intracoronary electrocardiogram

The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?